P-424 Partial Response or Better at 6 Months is Not Shown to Be a Prognostic Indicator of Progression-Free Survival in Waldenström Macroglobulinemia Treated with Acalabrutinib: a Post Hoc Analysis
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA（2023）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要